For: | Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, Qiao LX, Guo XH, Yang TW, Chen DX. Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol 2023; 15(4): 460-476 [PMID: 37206651 DOI: 10.4254/wjh.v15.i4.460] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v15/i4/460.htm |
Number | Citing Articles |
1 |
Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490
|
2 |
Yong-Gang He, Zheng Wang, Jing Li, Wang Xi, Chong-Yu Zhao, Xiao-Bing Huang, Lu Zheng. Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report. World Journal of Gastrointestinal Oncology 2024; 16(11): 4506-4513 doi: 10.4251/wjgo.v16.i11.4506
|
3 |
Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen. Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International Journal of Molecular Sciences 2023; 25(1): 433 doi: 10.3390/ijms25010433
|
4 |
Shiheng Wu, Xinxing Zhang, Jin Bao, Naiying Sun, Wenjun Guo, Baogui Wang, Xingjie Yang. Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report. Oncology Letters 2023; 27(2) doi: 10.3892/ol.2023.14207
|
5 |
S. Vancoillie, E. Willems, C. De Meyere, I. Parmentier, C. Verslype, Mathieu D'Hondt. Robotic versus laparoscopic repeat hepatectomy: A comparative single-center study of perioperative outcomes. European Journal of Surgical Oncology 2025; 51(1): 109376 doi: 10.1016/j.ejso.2024.109376
|
6 |
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Abstract(371) |
Core Tip(372) |
Full Article(HTML)(1703)
|
Full Article with Cover (PDF)-3548K(124)
|
Full Article (Word)-242K(21)
|
Audio-234K(10)
|
Peer-Review Report-224K(68)
|
Answering Reviewers-264K(55)
|
Full Article (PDF)-550K(111)
|
Full Article (XML)-38K(47)
|
Times Cited (2)
|
Total Visits (4225)
|
Open
|
7 |
Zijie Wu, Zehua Dong, Jiangti Luo, Weiwei Hu, Yue Tong, Xiangdong Gao, Wenbing Yao, Hong Tian, Xiaosheng Wang. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis. Genomics 2024; 116(3): 110831 doi: 10.1016/j.ygeno.2024.110831
|
8 |
Ravi Parhar, Prakash Ramachandran. Sinusoidal Cells in Liver Diseases. 2024; : 111 doi: 10.1016/B978-0-323-95262-0.00006-1
|
9 |
Lien-Hung Huang, Shao-Chun Wu, Yueh-Wei Liu, Hang-Tsung Liu, Peng-Chen Chien, Hui-Ping Lin, Chia-Jung Wu, Ting-Min Hsieh, Ching-Hua Hsieh. Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(22): 11969 doi: 10.3390/ijms252211969
|
10 |
Guangce Xia, Yulin Guo, Jiajia Zhang, Meng Han, Xiangchao Meng, Ji Lv. An Overview of the Deubiquitinase USP53: A Promising Diagnostic
Marker and Therapeutic Target. Current Protein & Peptide Science 2024; 25(9): 708 doi: 10.2174/0113892037292440240518194922
|